RKDA: Arcadia Biosciences, Inc. Company Profile & Statistics

Arcadia Biosciences, Inc. Profile

About

Arcadia Biosciences Inc. is a producer and marketer of plant-based health and wellness products. Arcadia Biosciences Inc. is based in DALLAS.

Info & Links

CEO

Thomas J. Schaefer

Headquarters

5950 Sherry Lane, SUITE 215
Dallas, TX 75225, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

Employees

Arcadia Biosciences, Inc. Statistics

Valuation Measures

Market Capitalization²

4.95M

Enterprise Value

3.83M

Enterprise Value/EBITDA(ttm)

-1.19

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

0.97

Price to Book(mrq)

0.92

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

37.64%

Operating Margin(ttm)

-10.67%

Profit Margin(ttm)

-89.64%

Return on Equity(ttm)

-8.80%

Return on Invested Capital(ttm)

-118.32%

Return on Assets(ttm)

-5.15%

Income Statement

Revenue(ttm)

5.17M

Revenue Per Share(ttm)

3.77

Gross Profit(ttm)

1.96M

EBITDA(ttm)³

-3.22M

Net Income Available to Common(ttm)

-5.07M

Diluted EPS(ttm)

Share Statistics

Beta (5Y Monthly)

0.57

52-Week Change

41.46%

S&P 500 52-Week Change

10.28%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

1.37M

Dividend Yield

0.00%

Float⁴

1.35M

% Held by Insiders

1.80%

% Held by Institutions

17.73%

Balance Sheet

Total Cash(mrq)

5.88M

Total Cash Per Share(mrq)

4.29

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.67%

Quick Ratio(mrq)

3.03%

Book Value Per Share(mrq)

3.98

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.83

Free Cash Flow(ytd)

-3.88M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

RKDA

Arcadia Biosciences, Inc.